Abstract
The study was undertaken to develop and characterize docetaxel-loaded lyophilized block co-polymeric micelles for cancer therapy treatment. The study demonstrates that micellar size, shape, zeta potential, and other characteristics of lyophilized polymeric micelles are appropriate; furthermore, because of the polymer's encapsulation and capacity to maintain the drug release, significantly reduces toxicity and adverse effects. Block co-polymeric micelles offer improved solubility and a high capacity for drug loading, perhaps enhancing the bioavailability. As per this research, the idea of employing block co-polymeric micelles to enhance the solubility of hydrophobic medications holds excellent promise as an intravenous drug delivery system. While the outcomes are encouraging, the docetaxel-loaded block co-polymeric micelles must be further evaluated for In-Vivo studies to check the targeted drug delivery.Bottom of Form
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Clinical Pharmacokinetics and Medical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
